Important to women
Intuitive Surgical received FDA clearance to market da Vinci Surgery for gynecologic applications in April 2005, nearly four years after its clearance for prostatectomy. In just a few years, da Vinci Gynecologic Surgery has seen significant adoption among surgeons, providing an indicator of what could be the next surgical standard of care in gynecologic surgery.
Ad Statistics
Times Displayed: 50697
Times Visited: 1465 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Hysterectomies are the most common female surgery: According to the U.S. Department of Health and Human Services, one in three women in the United States will have a hysterectomy before she turns 60. While most hysterectomies are still performed using an open incision, robotic surgery is being introduced to treat many complex gynecological conditions. It address excessive bleeding, fibroids, endometriosis, uterine prolapse, cancer and pre-cancer. Robotic surgery only requires a few tiny incisions and patients can return to a normal lifestyle within days rather than weeks.
da Vinci's Creator
Intuitive Surgical (ISRG), Sunnyvale, CA currently has a lock on the robotic surgery market. Highlights of Intuitive Surgical's third quarter 2008 financials included total revenue growth of 50% to $236 million. During that time, 91 da Vinci Surgical Systems were sold, an increase of 44% compared to the third quarter of 2007. President and CEO Lonnie Smith says, "These results reflect the continued adoption of robotic surgery as a growing number of patients benefit from the improved clinical outcomes and reduced surgical trauma that our da Vinci products enable."
Intuitive da Vinci S
Surgical System performing
a procedure
The da Vinci Surgical System is the only device of its kind approved for clinical use by the FDA available on the market. As of September 2008, there have been 1,032 unit shipments worldwide - 776 in the United States, 171 in Europe and 85 to the rest of the world. The average cost of the da Vinci Surgical System is $1.3 million.
Due to the success of this company, a great deal of interest is brewing in the industry and market entry from other larger medical device and robotic companies may be on the horizon. The competition should bring the cost of surgical robotic systems down and lead to wider usage in less developed areas.
